Effectiveness of Virtual Reality Vision Therapy - VERVE
Status unconfirmed · Early Phase 1
Conditions studied: Convergence Insufficiency
In brief
The purpose of this research study is to see how well the treatment of a participant's eye coordination and/or focusing problems improves eye muscle responses and symptoms of eyestrain. We will use an entertainment device called a virtual reality headset to play a custom-designed video game to find out how well the treatment of binocular vision improves a participant's coordination and/or focusing problem. The virtual reality headset uses eye-trackers to monitor progress in a totally objective manner. Objective testing allows the doctor to determine the results without relying on a participant's ability to answer questions or respond verbally in any way. We will compare the results of a participant before and after playing the video game.
Key facts
- Study ID
- NCT04691427
- Run by
- OculoMotor Technologies
- People needed
- 50
- Starts
- 2021-10-14
- Expected to finish
- 2024-09-01
- Last updated by the study team
- 2024-04-16
Who can join
Age: 9 and older, up to 35. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 9 years and older
- CISS score ≥ 16
- Best-corrected distance visual acuity of 20/25 or better in each eye
- Random dot stereopsis appreciation of 500 seconds of arc or better
- Parent or subject understands the protocol and is willing to enroll in the study
You may not qualify if…
- Constant strabismus at distance or near
- Vertical heterophoria ≥ 2 ∆ at distance or near
- ≥ 2 line interocular difference in best-corrected visual acuity
- Near point of accommodation > 20 cm in either eye as measured by push-up method
- Manifest or latent nystagmus
- Non-strabismic binocular vision and accommodative disorders associated with known disease of the brain
- Diseases known to affect accommodation, vergence, or ocular motility such as multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, Parkinson disease
- Any ocular or systemic medication known to affect accommodation or vergence such as anti-anxiety agents (e.g., Librium or Valium), anti-arrhythmic agents (e.g., Cifenline, Cibenzoline), anti-cholinergics, bladder spasmolytic drugs (e.g., Propiverine), hydroxychloroquine, chloroquine, phenothiazines (e.g., Compazine, Mellaril, Thorazine), tricyclic antidepressants (e.g., Elavil, Nortriptyline, Tofranil)
- Inability to comprehend and/or perform any study-related test or procedure
Where it is running
- OculoMotor Technologies — Newark, New Jersey, United States (enrolling)
- The Eye Institute at Salus University — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.